|
February 26, 2003
MEDICURE ANNOUNCES CONVERSION OF CLASS A COMMON SHARES
WINNIPEG,
Manitoba - (February 26, 2003) - Medicure
Inc., a cardiovascular biotechnology company, is pleased
to announce that as of March 1, 2003, all of the issued and outstanding
Class A Common Shares (TSX: MPH.A) - totaling 1,280,000 shares -
shall be converted into Common Shares of the Company on the basis
of one Common Share for each Class A Common Share in accordance
with the Company's Articles of Continuance.
The Common Shares
and the Class A Common Shares are identical in all respects with
the only distinction being that the Class A Common Shares are eligible
for the Manitoba Equity Tax Credit which expires on February 28,
2003. As of March 1, 2003 there will be no legal distinction between
the Company's Common Shares and the Class A Common Shares. On Monday,
March 3, 2003, the Common Shares, under the ticker symbol MPH, will
represent the only issued and outstanding shares of the Company
that are publicly traded on the Toronto Stock Exchange. Class A
Common shareholders require no further action as the Class A Common
Share certificates will represent Common Share certificates until
replaced against future transfer in ownership by the transfer agent.
About Medicure
Inc.
Medicure Inc. is a cardiovascular
drug discovery and development Company focused on developing effective
therapeutics for unmet needs in the field of cardiovascular medicine
including the prevention and treatment of ischemia, ischemic reperfusion
injury, and stroke.
This press release
contains forward-looking statements that involve risks, which may
cause actual results to differ materially from the statements made,
and accordingly may be deemed to be forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. The forward-looking statements are
made as of the date hereof, and the Company disclaims any intention
and has no obligation or responsibility to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
For additional
information contact:
Don Bain
Director of Investor & Public Relations
E: info@medicure.com
Derek Reimer
Chief Financial Officer
E: dgreimer@medicure.com
Medicure Inc.
Tel. 204-487-7412
Fax 204-488-9823
info@medicure.com
Back to 2003 News Archives
|
|
